课题基金 / 基金详情

Pre-commercial development of single cell antibody selection process

Pre-commercial development of single cell antibody selection process
单细胞抗体选择流程的商业化前开发
批准号:
256777
负责人:
Hansen Carl L
金额:
$11.23万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2012
资助国家:
加拿大
项目状态:
已结题
起止时间:
2012-02-01 至 2013-02-01

项目摘要

项目成果

Hansen Carl L的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This proposal brings together expertise in engineering and immunology to develop a commercial technology that addresses a pivotal problem in basic and applied medical research - the rapid and inexpensive generation of monoclonal antibodies. In response to
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Microfluidic technology platform for selection of functional monoclonal antibodies with application to fibrosis
  • 批准号:
    316153
  • 项目类别:
    Operating Grants
  • 资助金额:
    $32.24万
  • 财政年份:
    2014
  • 负责人:
    Hansen Carl L
  • 依托单位:
A high-throughput single-cell technology for the function-based discovery of monoclonal antibody antagonists of G-protein coupled receptors in cancer
  • 批准号:
    307343
  • 项目类别:
    Operating Grants
  • 资助金额:
    $89.81万
  • 财政年份:
    2014
  • 负责人:
    Hansen Carl L
  • 依托单位:
The development of single cell microfluidic technologies for analysis of microRNA expression and epigenetic state with application to hematopoietic stem cells
  • 批准号:
    248047
  • 项目类别:
    Operating Grants
  • 资助金额:
    $55.25万
  • 财政年份:
    2011
  • 负责人:
    Hansen Carl L
  • 依托单位:
Deciphering signalling complexity at the single cell level using high-throughput microfluidic imaging.
  • 批准号:
    191823
  • 项目类别:
    Operating Grants
  • 资助金额:
    $0.07万
  • 财政年份:
    2009
  • 负责人:
    Hansen Carl L
  • 依托单位:
海外基金